Medios AG / Key word(s): Takeover/Miscellaneous

06-Jan-2017 / 11:09 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Medios AG: Complete acquisition of Medios Manufaktur GmbH

Berlin, January 6, 2017 - Medios AG intends to acquire the remaining shares
of Medios Manufaktur GmbH corresponding to a 49% stake in its share capital
for a total of EUR8,820,004 in accordance with the resolution adopted by
the general meeting on September 14, 2016, and the contribution and
purchase agreement dated October 13, 2016.

As part of a capital increase by in-kind contribution, 51% of the shares
were already contributed to Medios AG in 2016. The intent of the
acquisition's structure is for all shares to be assigned to Medios AG by
payment of a partial purchase price of EUR6,000,000. The remaining purchase
price is to be paid at semi-annual installments in accordance with the
purchase agreement.

Medios AG
Matthias Gärtner, board member

About Medios AG

Medios AG, along with its subsidiaries Medios Pharma GmbH and Medios
Manufaktur GmbH, has positioned itself in the specialty pharma segment as
the go-to source for expertise and solutions. It brings together individual
market players in a network of cooperating partners. Our objective is to
ensure that patients have optimum access to pharmaceutical drugs and to
offer integrated solutions along the value-added chain to partners and
customers. Specialty pharmaceutical drugs are medications for patients with
rare and/or chronic illnesses (for example, certain cancers, or autoimmune
diseases and infectious diseases) that require lengthy and expensive
treatment.

Contact

Medios AG
Matthias Gärtner
Friedrichstraße 113a
10117 Berlin

Phone: +49 30 232 5668 0
Fax: +49 30 232 5668 66

E-mail: ir@medios.ag
www.medios.ag

Disclaimer

This notification contains forward-looking statements that are subject to
certain risks and uncertainties. Future results may significantly deviate
from currently expected results, specifically due to various risk factors
and uncertainties such as changes in business, economic, and competitive
circumstances, exchange rate fluctuations, uncertainties about legal
disputes or investigations, and the availability of financial resources.
Medios AG assumes no responsibility whatsoever for updating the forward-
looking statements contained in this notification.

---------------------------------------------------------------------------

06-Jan-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

   Language:    English
   Company:     Medios AG
                Friedrichstraße 113a
                10117 Berlin
                Germany
   Phone:       +49 30 232 566 - 800
   Fax:         030 / 8321 8377
   E-mail:      ir@medios.ag
   Internet:    www.medios.ag
   ISIN:        DE000A1MMCC8
   WKN:         A1MMCC
   Listed:      Regulated Market in Frankfurt (General Standard), Hamburg;
                Regulated Unofficial Market in Dusseldorf



     End of Announcement    DGAP News Service